Lung Volume Reduction Surgery (Clinical Cases)

Abstract

Emphysema is a chronic lung disease in which the walls of the alveoli in the lungs weaken and collapse; leaving abnormally large residual spaces filled with air even when the patient exhales. The most common symptoms of emphysema are shortness of breath (dyspnea); cough; fatigue; and weight loss. Emphysema often coexists with chronic obstructive pulmonary disease. The treatment of emphysema requires a multidisciplinary approach; including education; exercise; tobacco cessation; oral and inhaled medications; oxygen therapy; and lung transplantation. Lung volume reduction surgery (LVRS) may be an option for patients who experience shortness of breath and whose pulmonary function tests show severe obstruction and enlarged lungs. The surgery aims to remove the least functional part of the lung to improve airflow; diaphragm; and chest wall mechanics; as well as alveolar gas exchange in the remaining lung. Objective — to familiarize doctors with the clinic’s experience in reducing lung volume in patients with bullous emphysema. Materials and methods. Our clinic performed the following surgical interventions to reduce lung volume: VATS resection of large (giant) lung bullae — 14 (77.7 %) cases; VATS lo­­bec­tomy — 2 (11.1 %); lobectomy through thoracotomy — 1 (5.6 %); VATS sublobar resection — 1 (5.6 %). Results and discussion. There were no fatalities. The following postoperative complications were recorded: prolonged under-expansion of the operated lung in 5 (27.7 %) cases; empyema of the residual pleural cavity with bronchial fistula in 1 (5.6 %). The overall incidence of postoperative complications was 33.3 %. Two patients with prolonged underdistension of the operated lung required reoperation (VATS revision of the pleural cavity and redilation). The patient who developed pleural empyema with a bronchial fistula underwent bronchial blockage with a satisfactory result. In all cases of LVRS; a positive clinical effect was recorded in the first 3 months after surgery. During the follow-up period of up to 2 years; only 2 (11.1 %) patients showed no clinical effect and signs of progression of chronic obstructive pulmonary disease and respiratory failure were observed. Conclusions. Lung volume reduction surgery is a method of treating bullous lung disease that allows achieving overall treatment effectiveness in the follow-up period of up to 3 months in 100 % of cases; and in the follow-up period of up to 2 years — in 89.9 %. The high rate of postoperative complications in LVRS requires a physician to carefully select patients for surgery and monitor their condition daily in the postoperative period.